Omipalisib reduces hyperphosphorylated tau protein by modulating mTOR-autophagy pathway

Haeun Hwang, Namkwon Kim, Subyn Jeon, Yoojin Lee, Jeongmin Son, Seung Ho Jeon, Yeongae Lee, Min Sung Gee · 2026

Read Omipalisib reduces hyperphosphorylated tau protein by modulating mTOR-autophagy pathway by Haeun Hwang, Namkwon Kim, Subyn Jeon, Yoojin Lee, Jeongmin Son, Seung Ho Jeon, Yeongae Lee, Min Sung Gee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0352120.txt.

Description

Haeun Hwang and colleagues tested whether a cancer drug, omipalisib, can help brain cells clear out the tangled tau protein behind a family of dementias. Tau tangles grow when the cell's recycling system, autophagy, falters. The drug blocks a growth switch called mTOR, which normally holds recycling back. The team tried it in human cells engineered to make a mutant tau and in mice bred to develop tau disease.

In the cells, the drug loosened the mTOR brake, raised recycling markers, and lowered both a recycling backlog protein and the harmful modified form of tau, without killing the cells. Mice received the drug for two months starting at six months of age. The work supports the idea that freeing the cell's cleanup crew can cut tau buildup, a strategy now open to further testing in animals.

Catalog record

CREATORHaeun Hwang, Namkwon Kim, Subyn Jeon, Yoojin Lee, Jeongmin Son, Seung Ho Jeon, Yeongae Lee, Min Sung Gee
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30451
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0352120

Browse the full library · About the Tower of Babel